Table 2.
Unadjusted prevalence of diagnoses
| Cannabis Use Disorder (CUD) – Documented N = 729 |
Cannabis Use (no disorder) (CU)-documented N = 3,741 |
Matched Controls N = 4,470 |
|
|---|---|---|---|
| General Medical Conditions | |||
| Cancer | 20.6% | 22.1% | 15.4% |
| Diabetes Mellitus | 11.8% | 7.9% | 6.4% |
| Nervous System Disease | 64.5% | 52.2% | 37.5% |
| Sleep Disorders | 34.7% | 23.2% | 12.1% |
| Circulatory System Disease | 45.7% | 38.7% | 29.7% |
| Respiratory Disease | 63.0% | 53.9% | 43.3% |
| Digestive System Disease | 58.2% | 49.1% | 34.2% |
| Liver Disease | 12.6% | 8.4% | 5.2% |
| Musculoskeletal Disease | 66.9% | 62.3% | 51.0% |
| HIV/AIDS | 3.7% | 0.8% | 0.8% |
| Sexually Transmitted Disease | 7.1% | 3.9% | 1.8% |
| Other Than HIV/AIDS | |||
| Mental Health Disorders | 71.1% | 44.4% | 21.9% |
| Alcohol Use Disorder | 26.2% | 6.5% | 2.6% |
| Tobacco Use Disorder | 36.6% | 14.5% | 4.9% |
| Substance Use Disorder (other than alcohol, cannabis, tobacco) | 44.7% | 13.8% | 4.5% |
| Conditions Known To Be Associated With Cannabis | |||
| Respiratory Disease | 63.0% | 53.9% | 43.3% |
| COPD | 26.2% | 18.7% | 13.1% |
| Cancer | 20.6% | 22.1% | 15.4% |
| Ischemic Heart Disease | 11.8% | 7.3% | 4.9% |
| Obstructive Sleep Apnea | 7.5% | 6.6% | 3.5% |
| Multiple Sclerosis | 0.8% | 0.7% | 0.2% |
| HIV/AIDS | 3.7% | 0.8% | 0.8% |
| Tourette Syndrome | 0.0% | 0.1% | 0.0% |
| Testicular Cancer | 0.5% | 0.2% | 0.3% |
| Chronic Pain | 70.0% | 64.7% | 52.5% |
| Schizophrenia/Psychotic Disorder | 6.6% | 1.7% | 0.8% |
| Depression | 50.3% | 26.3% | 12.4% |
| Anxiety | 60.1% | 36.3% | 16.8% |
| Bipolar Disorder | 11.1% | 4.2% | 1.5% |
| Social Anxiety Disorder | 2.9% | 0.6% | 0.4% |
| Post-Traumatic Stress Disorder | 7.4% | 1.8% | 0.6% |
| Alcohol Use Disorder | 26.2% | 6.5% | 2.6% |
| Substance Use Disorder (other than cannabis, alcohol, tobacco) | 44.7% | 13.8% | 4.5% |